Objective: Multiple sclerosis (MS) is an autoimmune disease with inflammatory and demyelinating lesions in the nervous system, characterized by lymphocytic infiltration and damage to axons. In some studies, conducted in ...

Hepatic disorders have led to treatment delay and in some cases treatment interruption and resumption of treatment, in addition to the complications caused by the liver itself, it causes the recurrence of the underlying ...

COPD is the fourth leading cause of death in the United States after cardiovascular disease, cancer, and cerebrovascular disease, and by 2030, COPD will become the third leading cause of death worldwide, and its prevalence ...

In patients where the testis cannot be palpated within the scrotum or at any point in the inguinal canal, surgeons typically begin with laparoscopic exploration to assess the abdomen. If no intra-abdominal testis is found ...

Colorectal cancer is known as the third most common cancer and cause of cancer death in the world. The aim of this study was to investigate expression of DLEU1 and TRAF4 genes in colorectal cancer patients and effect of ...

Social prescribing is promoted as an effective way to address social issues relating with health and well-being. The aim of this study is the evaluation of the opinions of last year medical students of Tabriz University ...

One of the ways to preserve fertility in women with cancer is ovarian tissue transplantation. Measures such as the use of scaffolds, antioxidants, growth factors and hormones have been used to accelerate the resumption of ...

Acanthamoeba is a resistant protozoan responsible for severe diseases such as granulomatous amebic encephalitis (GAE) and Acanthamoeba keratitis (AK). Due to the ineffectiveness of many existing drugs against this parasite, ...

Cardiovascular diseases are one of the most common disorders and the main cause of death and disability in most countries of the world. One of the cardiovascular diseases are heart tumors. Performing heart surgeries for ...

The vast majority of kidney transplant recipients receive the immunosuppressive drug tacrolimus to prevent graft rejection. One of the key challenges with tacrolimus is its narrow therapeutic window, meaning that the ...